Factors Associated With Neurocognitive Impairment Following Chemoradiotherapy in Patients With High-Grade Glioma: Results of a Prospective Trial-Reference-Cited by-同舟云学术

Factors Associated With Neurocognitive Impairment Following Chemoradiotherapy in Patients With High-Grade Glioma: Results of a Prospective Trial

Published:2023 Issue:3 Volume:11 Page:183
ISSN:2288-2405
Container-title:Brain Tumor Research and Treatment
language:en
Short-container-title:Brain Tumor Res Treat

Author:

Sharma Prashasti¹^ORCID,Medhi Partha Pratim²^ORCID,Kalita Apurba Kumar¹^ORCID,Bhattacharyya Mouchumee¹^ORCID,Nath Jyotiman¹^ORCID,Sarma Gautam²^ORCID,Yanthan Yanpothung¹^ORCID

Affiliation:

1. Department of Radiation Oncology, Dr. B. Borooah Cancer Institute, Guwahati, Assam, India.

2. Department of Radiation Oncology, All India Institute of Medical Sciences, Guwahati, Assam, India.

Publisher

XMLink

Subject

General Earth and Planetary Sciences,General Engineering,General Environmental Science

Link

https://btrt.org/pdf/10.14791/btrt.2023.0004

Reference35 articles.

1. The 2007 WHO Classification of Tumours of the Central Nervous System

2. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

3. The Central Nervous System-Restricted Transcription Factor Olig2 Opposes p53 Responses to Genotoxic Damage in Neural Progenitors and Malignant Glioma

4. First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinician perspectives on integrating neuro-oncology and palliative care for patients with high-grade glioma;Neuro-Oncology Practice;2024-03-14